Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- In vitro Mammalian Cell Gene Mutation Tests using the Hprt and xprt genes
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 21 October 2019 TO 09 April 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- adopted on 29th July 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: In vitro Mammalian Cell Gene Mutation Tests using the Hprt and xprt genes
Test material
- Reference substance name:
- Reaction products of DL-methionine and C18 unsaturated fatty acid chloride and isopropanol
- Molecular formula:
- not applicable (UVCB)
- IUPAC Name:
- Reaction products of DL-methionine and C18 unsaturated fatty acid chloride and isopropanol
1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Clariant Ibérica Producción,S.A.
- Batch: ESD0033040
- Expiration date of the batch: August 2021
- Purity : UVCB substance; purity ca 97%
STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Ambient (21 to 29°C)
- Solubility of the test substance in the solvent/vehicle: miscible in DMSO
Method
- Target gene:
- HPRT gene
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- The derivative of the CHO-K1, CHO AA8 Cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- induced rat liver S9 homogenate
- Test concentrations with justification for top dose:
- moderate precipitation was observed at 0.25 µL/mL and the Relative Survival was greater than 10%. Therefore 0.125 µL/mL was selected as the highest concentration for testing in gene mutation test.
(four concentrations i.e. 0.015625, 0.03125, 0.0625 and 0.125 µL/mL were selected for gene mutation test) - Vehicle / solvent:
- dimethyl sulphoxide
Controls
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Details on test system and experimental conditions:
- CHO AA8 cells, Batch No.5000062 procured from American Type Culture Collection (ATCC).
- Evaluation criteria:
- • The concurrent vehicle control is considered acceptable for addition to the laboratory historical vehicle control database
• Concurrent positive controls should induce responses that are compatible with those generated in the historical positive control data base and produce a statistically significant increase compared with the concurrent negative/vehicle control
A test chemical is considered to be clearly positive if, in any of the experimental conditions examined:
• At least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control.
• The increase is concentration-related when evaluated with an appropriate trend test.
• Any of the results are outside the distribution of the historical negative/vehicle control data.
When all of these criteria are met, the test chemical is then considered able to induce gene mutations in cultured mammalian cells in this test system.
• A test chemical is considered clearly negative if, in all experimental conditions examined:
• None of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control.
• There is no concentration-related increase when evaluated with an appropriate trend test.
• All results are inside the distribution of the historical negative/vehicle control data. - Statistics:
- Data of mutant frequencies were analyzed for differences among vehicle control, treatment and positive control groups by performing power transformation procedure by Snee and Irr (1981) with which, the observed mutant frequency was transformed using the formula:
Y=〖(X+A)〗^B
Where,
Y = transformed mutant frequency, X = observed mutant frequency
[Where X=(No. of mutant colonies per replicate)/(ACE value)×100
and A, B = constants (viz. A = 1 and B = 0.15)]
Statistical analysis of the experimental data was carried out using SPSS Statistical package version 22.0.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No change in pH was observed in any of the test concentrations.
- Water solubility: No
- Precipitation: No change in precipitation was observed at the tested concentrations 0.03125 and 0.0625 µL/mL, slight precipitation was observed at 0.125 µL/mL, moderate precipitation was observed at 0.25 µL/mL and heavy precipitation was observed at 0.50, 1 and 2 µL/mL.
RANGE-FINDING STUDIES: Pre study conducted to select highest test concentration.
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data:
Positive Control- Benzo(a)pyrene and 4- Nitroquinoline N-oxide
With Metabolic Activation
(3 to 6 hours)
[Benzo(a)pyrene] Without Metabolic Activation
(3 to 6 hours)
[4 Nitroquinoline N-oxide]
Mean Data of Mutant Frequency/2x106 Cells 261.94 264.60
Standard
Deviation 27.28 18.52
Margin of Error 17.82 12.10
Upper bound 279.76 276.70
Lower bound 244.12 252.50
- Negative (solvent/vehicle) historical control data:
Vehicle-DMSO
With Metabolic Activation
(3 to 6 hours) Without Metabolic Activation
(3 to 6 hours)
Mean Data of Mutant Frequency/2x106 Cells 24.51 25.43
Standard
Deviation 2.81 1.89
Margin of Error 1.95 1.31
Upper bound 26.46 26.74
Lower bound 22.56 24.12
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: Yes - Remarks on result:
- other:
- Remarks:
- Non mutagenic
Any other information on results incl. tables
TABLE 1. SUMMARY OF INITIAL CYTOTOXICITY TEST
Refer: Appendix 1
Set No. |
Treatment |
Concentration (µL/mL) |
Average Colony Count± SD |
Cloning Efficiency (CE) |
Adjusted Cloning Efficiency (ACE) |
Relative Survival (RS) (%) |
|||||||||||
Set 1 +S9 |
Vehicle Control (DMSO) |
- |
183.33 |
± |
7.57 |
0.92 |
1.17 |
- |
|||||||||
Dodicor V 5654 |
0.0078125 |
172.00 |
± |
3.00 |
0.86 |
1.07 |
91.45 |
||||||||||
0.015625 |
163.00 |
± |
8.19 |
0.82 |
0.99 |
84.62 |
|||||||||||
0.03125 |
143.00 |
± |
4.36 |
0.72 |
0.85 |
72.65 |
|||||||||||
0.0625 |
103.00 |
± |
4.58 |
0.52 |
0.50 |
42.74 |
|||||||||||
0.125 |
76.67 |
± |
5.13 |
0.38 |
0.31 |
26.50 |
|||||||||||
Set 2 -S9 |
Vehicle Control (DMSO) |
- |
179.00 |
± |
6.56 |
0.90 |
1.10 |
- |
|||||||||
Dodicor V 5654 |
0.0078125 |
162.67 |
± |
4.04 |
0.81 |
0.97 |
88.18 |
||||||||||
0.015625 |
152.33 |
± |
7.51 |
0.76 |
0.90 |
81.82 |
|||||||||||
0.03125 |
136.00 |
± |
7.21 |
0.68 |
0.73 |
66.36 |
|||||||||||
0.0625 |
101.33 |
± |
3.51 |
0.51 |
0.48 |
43.64 |
|||||||||||
0.125 |
62.33 |
± |
4.93 |
0.31 |
0.27 |
24.55 |
+S9: with metabolic activation; -S9: without metabolic activation;
Adjusted CE = CE × Number of cells at the end of treatment/number of cells at the beginning of treatment.
RS = Adjusted CE in treated culture/Adjusted CE in the vehicle control × 100.
CE = Number of colonies/Number of cells plated.
TABLE 2. SUMMARY OF PARALLEL CYTOTOXICITY TEST- GENE MUTATION TEST
Refer: Appendix 2
Set No. |
Treatment |
Concentration (µL/mL) |
Average Colony Count ± SD |
Cloning Efficiency (CE) |
Adjusted Cloning Efficiency (ACE) |
Relative Survival (RS) (%) |
||
Set 1 +S9 |
Vehicle Control (DMSO) |
- |
182.00 |
± |
3.61 |
0.91 |
1.14 |
- |
Dodicor V 5654 |
0.015625 |
174.00 |
± |
4.36 |
0.87 |
1.08 |
94.74 |
|
0.03125 |
173.00 |
± |
6.56 |
0.87 |
1.03 |
90.35 |
||
0.0625 |
95.67 |
± |
8.33 |
0.48 |
0.47 |
41.23 |
||
0.125 |
72.00 |
± |
4.36 |
0.36 |
0.31 |
27.19 |
||
Benzo(a)pyrene (Positive Control) |
3 µg/mL |
145.33 |
± |
10.02 |
0.73 |
0.77 |
67.54 |
|
Set 2 |
Vehicle Control (DMSO) |
- |
178.67 |
± |
10.02 |
0.89 |
1.09 |
- |
Dodicor V 5654 |
0.015625 |
172.00 |
± |
4.00 |
0.86 |
1.04 |
95.41 |
|
0.03125 |
166.33 |
± |
4.04 |
0.83 |
0.98 |
89.91 |
||
0.0625 |
102.67 |
± |
8.62 |
0.51 |
0.50 |
45.87 |
||
0.125 |
68.33 |
± |
14.05 |
0.34 |
0.31 |
28.44 |
||
4 Nitroquinoline N-oxide (Positive Control) |
1 µg/mL |
140.33 |
± |
8.50 |
0.70 |
0.71 |
65.14 |
+S9: with metabolic activation; -S9: without metabolic activation;
*Note: Cloning Efficiency = 200 cells plated for each replicate.
RS = Adjusted CE in treated culture/Adjusted CE in the vehicle control × 100.
CE = Number of colonies/Number of cells plated.
Adjusted CE = CE × Number of cells at the end of treatment/number of cells at the beginning of treatment.
Set No. |
Treatment |
Concentration (µL/mL) |
*Average Colony Count ± SD |
Cloning Efficiency in selective media |
Cloning Efficiency in non-selective media |
Total number of Mutant Colonies/ 2×106cells |
Mutant Frequency/ 2×106cells |
||
Set 1 +S9 |
Vehicle Control (DMSO) |
- |
188.00 |
± |
6.24 |
0.0000115 |
0.94 |
23 |
24.47 |
Dodicor V 5654 |
0.015625 |
175.00 |
± |
5.29 |
0.0000115 |
0.88 |
23 |
26.14 |
|
0.03125 |
181.33 |
± |
9.02 |
0.0000120 |
0.91 |
24 |
26.37 |
||
0.0625 |
168.33 |
± |
3.06 |
0.0000110 |
0.84 |
22 |
26.19 |
||
0.125 |
159.00 |
± |
4.58 |
0.0000100 |
0.80 |
20 |
25.00 |
||
Benzo(a)pyrene (Positive Control) |
3 µg/mL |
163.67 |
± |
8.50 |
0.0001060 |
0.82 |
212 |
258.54** |
|
Set 2 -S9 |
Vehicle Control (DMSO) |
- |
183.00 |
± |
7.21 |
0.0000120 |
0.92 |
24 |
26.09 |
Dodicor V 5654 |
0.015625 |
180.33 |
± |
1.53 |
0.0000115 |
0.90 |
23 |
25.56 |
|
0.03125 |
174.00 |
± |
7.00 |
0.0000105 |
0.87 |
21 |
24.14 |
||
0.0625 |
176.00 |
± |
8.54 |
0.0000115 |
0.88 |
23 |
26.14 |
||
0.125 |
164.33 |
± |
5.51 |
0.0000105 |
0.82 |
21 |
25.61 |
||
4 Nitroquinoline N-oxide (Positive Control) |
1 µg/mL |
152.67 |
± |
10.07 |
0.0001030 |
0.76 |
206 |
271.05** |
TABLE 3. SUMMARY OF GENE MUTATION TEST
Refer: Appendix 3
+S9: with metabolic activation; -S9: without metabolic activation; *Note: Cloning efficiency = 200 cells plated for each replicate.
**: Statistically significant (p˂0.05).
Mutant Frequency = Cloning efficiency of mutant colonies in selective medium/Cloning efficiency in non- selective medium.
Applicant's summary and conclusion
- Conclusions:
- Based on the results obtained, the test item, Dodicor V 5654 is considered as non-mutagenic at and upto the concentration of 0.125 µL/mL, both in the presence and absence of metabolic activation under the tested laboratory conditions.
- Executive summary:
The test itemDodicor V 5654was evaluated for gene mutation test in CHO AA8 cells.
The test item was found miscible in DMSO at 200 µL/mL. Precipitation test was conducted at 0.03125, 0.0625, 0.125, 0.25, 0.50, 1 and 2 µL/mL. Post 3 hours and
3 minutes of incubation, no change in precipitation was observed at the tested concentrations of 0.03125 and 0.0625 µL/mL, slight precipitation was observed at
0.125 µL/mL, moderate precipitation was observed at 0.25 µL/mL and heavy precipitation was observed at 0.50, 1 and 2 µL/mL. No change in pH was observed in any of the test concentrations.On the basis of precipitation results, 0.125 µL/mL was selected as the highest concentration for the initial cytotoxicity test. Initial cytotoxicity test was conducted at the concentrations of 0.0078125, 0.015625, 0.03125, 0.0625 and 0.125 µL/mL using DMSO as a vehicle in tetra plates/group in the presence and absence of metabolic activation (3 to 6 hours). Cytotoxicity was assessed by determining the Adjusted Cloning Efficiency and Relative Survival in the test.
The results of the initial cytotoxicity test indicated that the Relative Survival was greater than 10% (26.50% in presence of metabolic activation and24.55% in absence of metabolic activation) at 0.125 µL/mL when compared with the respective vehicle control, both in the presence and absence of metabolic activation. Based on these results, 0.125 µL/mL was selected as highest concentration for gene mutation test.
The gene mutation test was conducted at the concentrations of 0.015625, 0.03125, 0.0625 and 0.125 µL/mLusing DMSO as a vehicle in four plates/group in the presence and absence of metabolic activation (3 to 6 hours).
Benzo(a) pyrene and4 Nitroquinoline N-oxidewere used asPositive controlsfor the gene mutation test.
Cytotoxicity as Relative Survival was 27.19% in presence of metabolic activation and28.44% in absence of metabolic activation) at the highest tested concentration of 0.125 µL/mL.
There was no statistically significant increase in mutant frequencies at any of the concentrations tested when compared with the vehicle control. Moreover, treatment withDodicor V 5654resulted in mutant frequencies which fell within acceptable ranges with regard to historical controls.
There was statistically significant increase in mutant frequenciesfor positive controlswhen compared with the vehicle controlin both the phases of the experiment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.